EXAMINING THE COST BENEFIT OF EARLY INTERVENTION FOR SEVERE AORTIC STENOSIS

AORTIC STENOSIS IS UNDERTREATED DESPITE KNOWN CLINICAL BENEFITS The ACC/AHA Guideline mandated treatment for severe aortic stenosis (SAS) is aortic valve replacement (AVR)[1].   While over 67,000 AVRs are performed in America each year for aortic stenosis, population statistics estimate that over 500,000 people in America have severe aortic stenosis [2-4], illustrating that aortic stenosis is […]

Mitral Valve Prolapse

Mitral valve prolapse is the most commonly diagnosed heart valve abnormality, affecting five to ten percent of the world population.  A normal mitral valve consists of two thin leaflets, located between the left atrium and the left ventricle of the heart.  In patients with mitral valve prolapse, the mitral valve becomes affected by a process called […]

What’s New in Structural Heart Disease Treatment?

Structural heart disease may be congenital (present from birth), may occur as a result of an infection in the heart (endocarditis), from damage during a heart attack (post-infarction), or because of heart valve disease that progresses with age(most commonly aortic stenosis or mitral regurgitation).  Heart valve problems such as valve leaking(regurgitation) and valve stiffening(stenosis), if […]